Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
DFTX · against 1,372 other Healthcare companies
Ranked #675 of 1,373 · scores higher than 51% of peers · safety percentile 51
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)138 peers with a safety percentile of 50–59, including DFTX · Click a bar to see the companies
A mix: stronger current ratio and debt / equity, but weaker beta than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | DFTX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | 0.04× | 0.24× | 78% | 33% | |
| BetaLower is better · 1,320 reported | 2.24 | 0.53 | 3% | 33% | |
| Current ratioHigher is better · 1,338 reported | 6.95× | 2.62× | 82% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 671 | 2.2B USD | 51 | 82 | |
| 672 | 21.6B CNY (≈$3.0B) | 51 | 41 | |
| 673 | 14.41T IDR (≈$893M) | 51 | 69 | |
| 674 | 139M USD | 51 | 32 | |
| 675 | 4.5B USD | 51 | 33 | |
| 676 | 108.6B USD | 51 | 66 | |
| 677 | 4.2B USD | 51 | 44 | |
| 678 | 798.5B KRW (≈$575M) | 51 | 54 | |
| 679 | 15.0B CNY (≈$2.1B) | 51 | 55 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score